Literature DB >> 14750909

Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36.

Thomas E Elliott1, Colleen M Renier, Jeanette A Palcher.   

Abstract

OBJECTIVE: Depression is a major barrier to effective pain relief. The SF-36 Health Survey may be useful as an outcome measure for chronic pain patients with and without depression. The study purpose was to determine the correlation between the SF-36 Mental Composite Scale t-score and depression type in chronic pain patients and the positive predictive value of the SF-36 in classifying depression type in chronic pain patients.
DESIGN: Cross-sectional survey of chronic pain patients at baseline assessment.
SETTING: Interdisciplinary pain management center in the North Central United States. PATIENTS: Two hundred forty-two consecutive, chronic noncancer pain patients.
INTERVENTIONS: Assessments of patient-reported health-related quality of life (SF-36), pain, pain type and diagnoses, mental health diagnoses, and patient demographics. OUTCOME MEASURES: SF-36 Health Survey, pain diagnoses, and depression diagnoses.
RESULTS: Study participants were 160 women (66%) and 82 men (34%), 95% Caucasian, whose mean age was 46 (+/-0.8 SD) years (range: 19-83). All types and diagnoses of chronic pain were represented. The prevalence of major depressive disorder was 52%. The type of depression was highly correlated with SF-36 score (r=-0.567; P < 0.001). All chronic pain patients had very low SF-36 scores. Compared with U.S. population norms, chronic pain patients with and without depression had significantly lower SF-36 scores as measured by z-scores. Chronic pain patients with major depressive disorder had a significantly lower Mental Composite Score t-score than those with minor or no depression-34.1 and 47.6, respectively (P < 0.001). The positive predictive value of the SF-36 for differentiating major depression from minor or no depression was 98% (sensitivity=84.4%, specificity=93.9%).
CONCLUSIONS: The SF-36 Mental Composite Score and all subscales were highly correlated with depression type in chronic pain patients. The positive predictive value of the SF-36 in classifying depression type was high. The SF-36 may be a useful clinical tool to measure health-related quality of life in chronic pain patients. In addition, the SF-36 was able to detect major depression and demonstrate a dose-effect relationship between depression type (severity) and health-related quality of life in chronic pain patients.

Entities:  

Mesh:

Year:  2003        PMID: 14750909     DOI: 10.1111/j.1526-4637.2003.03040.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  59 in total

1.  [Health-related quality of life (SF-36) in chronic low back pain and comorbid depression].

Authors:  C Ahrens; M Schiltenwolf; H Wang
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

2.  Healthcare task difficulty among older adults with multimorbidity.

Authors:  Cynthia M Boyd; Jennifer L Wolff; Erin Giovannetti; Lisa Reider; Carlos Weiss; Qian-li Xue; Bruce Leff; Chad Boult; Travonia Hughes; Cynthia Rand
Journal:  Med Care       Date:  2014-03       Impact factor: 2.983

3.  Intersectional health-related stigma in persons living with HIV and chronic pain: implications for depressive symptoms.

Authors:  Burel R Goodin; Michael A Owens; Dyan M White; Larissa J Strath; Cesar Gonzalez; Rachael L Rainey; Jennifer I Okunbor; Sonya L Heath; Janet M Turan; Jessica S Merlin
Journal:  AIDS Care       Date:  2018-05-30

4.  Adverse impacts of chronic pain on health-related quality of life, work productivity, depression and anxiety in a community-based study.

Authors:  Kosuke Kawai; Alison Tse Kawai; Peter Wollan; Barbara P Yawn
Journal:  Fam Pract       Date:  2017-11-16       Impact factor: 2.267

5.  Psychological distress and quality of life are improved in autoimmune patients through Tandem-Psychotherapy, combining individual hypnosis and eye movement desensitization and reprocessing (EMDR) treatment for trauma, followed by supportive-expressive group therapy.

Authors:  Maria Teresa Corsetti; Edoardo Rossi; Sofia Bonvino; Pietro Randazzo
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

6.  Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Tara M Brinkman; Nicole J Ullrich; Nan Zhang; Daniel M Green; Lonnie K Zeltzer; Karen M Lommel; Pim Brouwers; Deo Kumar Srivastava; Neelam Jain; Leslie L Robison; Kevin R Krull
Journal:  J Cancer Surviv       Date:  2012-12-08       Impact factor: 4.442

7.  Prevalence, Severity, Exposures, and Treatment Patterns of Tinnitus in the United States.

Authors:  Jay M Bhatt; Harrison W Lin; Neil Bhattacharyya
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-10-01       Impact factor: 6.223

8.  Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.

Authors:  Hitoshi Yokoyama; Tomohiko Oguchi; William F Goins; James R Goss; Osamu Nishizawa; William C de Groat; Darren Wolfe; David M Krisky; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2013-02-14       Impact factor: 5.695

9.  History of opioid use as a risk factor for current use and mental health consequences among retired National Football League athletes: A 9-year follow-up investigation.

Authors:  Zachary L Mannes; Eugene M Dunne; Erin G Ferguson; Linda B Cottler; Nicole Ennis
Journal:  Drug Alcohol Depend       Date:  2020-08-28       Impact factor: 4.492

10.  The complexity of the relationship between chronic pain and quality of life: a study of the general Norwegian population.

Authors:  Astrid K Wahl; Tone Rustøen; Berit Rokne; Anners Lerdal; Øistein Knudsen; Christine Miaskowski; Torbjørn Moum
Journal:  Qual Life Res       Date:  2009-08-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.